New York Presbyterian Hospital/Columbia University Irving Medical Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian Hospital/Columbia University Irving Medical Center has participated in 7 clinical trials with 5 currently active.
Therapeutic areas: Myeloma, AL Amyloidosis, Peripheral Artery Disease.
Sponsors: Rajshekhar Chakraborty, MD, Philips Clinical & Medical Affairs Global, RTI Surgical.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Hospital/Columbia University Irving Medical Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Hospital/Columbia University Irving Medical Center has 7 clinical trials on record, with 5 currently active. Their work covers Myeloma, AL Amyloidosis, Peripheral Artery Disease.
Yes — New York Presbyterian Hospital/Columbia University Irving Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.